Paper Review Records
全部论文审稿周期
30 篇有效样本 · 按发表日期由新到旧排列
审稿天数=录用日期-收稿日期;保留 PDF/DOI/网页源链接
115
天
Psychosocial Well‐Being in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation and Their Caregivers: A Prospective Study
作者
E. Cavagna; A. Leoni; E. Morello; G. Benedini; G. Brambilla; M. A. Abrami; D. Avenoso; G. Magliano; S. Bernardi; M. Farina; V. Radici; D. Russo; M. Malagola展开收起
作者单位
1. Unit of Blood Diseases and Bone Marrow Transplantation, Department of Clinical and Experimental Science University of Brescia, ASST Spedali Civili di Brescia Brescia Italy; 2. ASST Spedali Civili di Brescia S.S.D. Psicologia Clinica Brescia Lombardy Italy; 3. Istituto di Medicina Molecolare “Angelo Nocivelli” ASST Spedali Civili di Brescia Brescia Italy展开收起
340
天
Geriatric Nutritional Risk Index Is Associated With Short‐ and Long‐Term Mortality in ICU Patients With Cancer: A Retrospective Study Based on MIMIC ‐ IV and eICU ‐ CRD Databases
作者
Zhikun Xu; Yichun Jiang; Jiayang Huang; Qinhua Yang; Yijing Su; Dongting Peng; Boru Wu; Zhiming Chen; Xueyan Liu展开收起
作者单位
1. Department of Critical Care Medicine Shenzhen People's Hospital (The First Affiliated Hospital, Southern University of Science and Technology, The Second Clinical Medical College, Jinan University) Shenzhen China; 2. Department of Pharmacy Shenzhen People's Hospital (The First Affiliated Hospital, Southern University of Science and Technology, The Second Clinical Medical College, Jinan University) Shenzhen China; 3. Department of Gastroenterology Shenzhen Luohu People's Hospital, The Third Affiliated Hospital of Shenzhen University Shenzhen China; 4. Department of Anesthesiology Shenzhen People's Hospital (The First Affiliated Hospital, Southern University of Science and Technology, The Second Clinical Medical College, Jinan University) Shenzhen China展开收起
227
天
Efficacy and Safety of Datopotamab Deruxtecan From a Single‐Institution Experience in Hormone Receptor–Positive, HER2 ‐Negative Metastatic Breast Cancer After Multiple Prior Therapies Including Antibody–Drug Conjugates
作者
Hiroko Shimada; Maki Todo; Hiroshi Ishiguro; Emi Mikami; Wakako Inohana; Taeko Kurosawa; Ayako Nakame; Ayaka Sakakibara; Yuki Ichinose; Akihiro Fujimoto; Asami Nukui; Aya Asano; Hideki Yokogawa; Masahiro Ohara; Kazuo Matsuura; Takahiro Hasebe; Nobuko Fujiuchi; Akihiko Osaki; Toshiaki Saeki展开收起
作者单位
1. Department of Breast Oncology Saitama Medical University International Medical Center Hidaka Saitama Japan; 2. Department of Pharmacy Saitama Medical University Saitama International Medical Center Hidaka Saitama Japan; 3. Department of Breast Oncology Saitama Medical University Hospital Moroyama‐machi, Iruma‐gun Saitama Japan展开收起
162
天
Lifetime Hormonal Exposure and Risk of Lung Cancer in Women: Results From a French Population‐Based Case–Control Study (The WELCA Study)
作者
Youssouf Gueye; Emilie Cordina Duverger; Pascal Guénel; Marie Wislez; Jean Trédaniel; Hélène Blons; Pierre Laurent‐Puig; Martine Antoine; Mireille Matrat; Loredana Radoï; Marianne Canonico; WELCA study group展开收起
作者单位
1. UVSQ, Inserm, Gustave Roussy, Equipe Exposome Hérédité Cancer et Santé, CESP, Université Paris‐Saclay Villejuif France; 2. Service d'Oncologie Thoracique Hôpital Cochin, Institut du Cancer Paris Carpem, Assistance Publique Hôpitaux de Paris (AP‐HP Centre), Centre de Recherche des Cordeliers, UMRS 1138 Complement, Inflammation and Cancers, Université Paris Cité Paris France; 3. Groupe Hospitalier Paris Saint Joseph, Université Paris Cité Paris France; 4. Centre de Recherche des Cordeliers, INSERM, CNRS SNC 5096, Sorbonne Université, Université Paris Cité Paris France; 5. Département de Médecine Génomique des Tumeurs et Cancers Assistance Publique Hôpitaux de Paris (AP‐HP Centre), Institut du Cancer Paris Carpem, Université Paris Cité Paris France; 6. Département de Pathologie Assistance Publique Hôpitaux de Paris (AP‐HP Centre), Hôpital Tenon Paris France; 7. Université Paris‐Est Créteil, UFR de Santé Créteil France; 8. Centre Hospitalier Intercommunal, Service des Pathologies Professionnelles et de l'Environnement Créteil France; 9. Faculté d'Odontologie Université Paris Cité Paris France; 10. Assistance Publique Hôpitaux de Paris (AP‐HP Nord) Colombes France; 11. UVSQ, Inserm, Equipe Epidémiologie Clinique et Pharmacoépidémiologie, CESP, Université Paris‐Saclay Villejuif France展开收起
60
天
Acute Lymphopenia and Recovery With Prophylactic Pelvic Nodal Radiotherapy in Oligometastatic Prostate Cancer: Interim Results From the Prospective PROLONG2 Cohort
作者
Xin Qi; Hewei Wang; Huan Zhang; Xueying Ren; Mingwei Ma; Xiaoying Li; Wanqi Zhang; Zhisong He; Yi Song; Cheng Shen; Wei Yu; Yu Fan; Xianshu Gao; Hongzhen Li展开收起
作者单位
1. Department of Radiation Oncology Peking University First Hospital Beijing China; 2. Department of Urology Peking University First Hospital Beijing China展开收起
160
天
Efficacy and Safety of Apixaban Thromboprophylaxis According to Baseline Chemotherapy Class in High‐Risk Ambulatory Cancer Patients: A Post Hoc Analysis of the AVERT Trial
作者
Nadia Linxi Feng; John Doering; Tzu‐Fei Wang; Ranjeeta Mallick; Grégoire Le Gal; Joseph Shaw; Danny Hill; Sudeep Shivakumar; Vicky Tagalakis; Phil Wells; Marc Carrier展开收起
作者单位
1. Faculty of Medicine McGill University Montreal Quebec Canada; 2. Department of Medicine University of British Columbia Vancouver British Columbia Canada; 3. Department of Medicine University of Ottawa at the Ottawa Hospital Ottawa Ontario Canada; 4. Method Center The Ottawa Hospital Research Institute Ottawa Ontario Canada; 5. Department of Medicine Sault Area Hospital Sault Ste. Marie Ontario Canada; 6. Department of Medicine Nova Scotia Health, Dalhousie University Halifax Nova Scotia Canada; 7. Jewish General Hospital, Lady Davis Institute for Medical Research McGill University Montreal Quebec Canada展开收起
FAQ
Cancer Medicine审稿要多久?
截至2026-11-17,CrushSCI 收录了 Cancer Medicine 的 30 篇完整审稿记录。最快一篇从收稿到录用用了 54 天(Comparative Cardiovascular Safety and Exploratory Bleeding Outcomes of Ibrutinib, Acalabrutinib, and Zanubrutinib in Mantle Cell Lymphoma: A Propensity Score‐Matched Real‐World Analysis,2026-05-11 收稿,2026-07-04 录用),最慢一篇用了 567 天;平均 220 天,中位数 208 天。
Expert Matching · Case Demo
把投稿要求,转成可验证的期刊方案
说清专业、时限和作者背景,CrushSCI 结合真实审稿样本,给出拟题方向、期刊初筛与周期判断。
